Introduction: pharmacogenetic approaches in the treatment of asthma

I. P. Hall (Nottingham, United Kingdom)

Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Session: Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Session type: Oral Presentation
Number: 4522
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. P. Hall (Nottingham, United Kingdom). Introduction: pharmacogenetic approaches in the treatment of asthma. Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacogenetics
Source: Annual Congress 2005 - MP15 - Pharmacogenetics
Year: 2005

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Gene polymorphisms in bronchial asthma
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007



New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?
Source: Eur Respir J 2002; 19: 1179-1193
Year: 2002



Recent developments in the genetics of asthma susceptibility and severity
Source: Eur Respir Mon 2011; 51: 82-96
Year: 2011


Evaluating the effects of asthma therapy on childhood growth: principles of study design
Source: Eur Respir J 2002; 19: 1167-1178
Year: 2002



Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008



Longitudinal patterns of asthma medication use in preschool children: results from the PIAMA-study
Source: Annual Congress 2005 - Epidemiology in childhood asthma
Year: 2005


Dose-FEV1 modeling to support future development of AZD2115, a dual acting bronchodilator for the treatment of COPD
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



Treatment of childhood asthma the current USA perspective
Source: Annual Congress 2006 - Childhood asthma therapy: where we are now and where we need to go
Year: 2006


Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005

Single nucleotide polymorphism and asthma: A study on the genetic basis of asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015


The genetics of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=26
Year: 2003

Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020


Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006



Systematic assessment of difficult-to-treat asthma
Source: Eur Respir J 2003; 22: 478-483
Year: 2003